TipRanks (Fri, 14-Aug 2:01 AM ET)
Atara Biotherapeutics Announces Second Quarter 2026 Financial Results and Operational Progress
Business Wire (Wed, 12-Aug 4:05 PM ET)
Atara Biotherapeutics Announces Changes to Its Board of Directors
Business Wire (Fri, 12-Jun 4:00 PM ET)
PRNewswire (Tue, 26-May 9:01 AM ET)
Business Wire (Fri, 22-May 2:41 PM ET)
Globe Newswire (Fri, 22-May 10:32 AM ET)
Business Wire (Fri, 22-May 9:17 AM ET)
Newsfile (Thu, 21-May 5:16 PM ET)
Globe Newswire (Thu, 21-May 4:52 PM ET)
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
Atara Biotherapeutics trades on the NASDAQ stock market under the symbol ATRA.
As of August 19, 2026, ATRA stock price climbed to $9.60 with 77,779 million shares trading.
ATRA has a beta of 2.33, meaning it tends to be more sensitive to market movements. ATRA has a correlation of 0.04 to the broad based SPY ETF.
ATRA has a market cap of $96.36 million. This is considered a Micro Cap stock.
Last quarter Atara Biotherapeutics reported $630,000 in Revenue and -$.32 earnings per share. This beat revenue expectation by $263,330 and missed earnings estimates by -$.07.
In the last 3 years, ATRA traded as high as $49.00 and as low as $3.92.
The top ETF exchange traded funds that ATRA belongs to (by Net Assets): VTI, VXF, IWC, BUSM, DFAS.
ATRA has underperformed the market in the last year with a return of -16.4%, while SPY returned +20.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ATRA shares. However, ATRA has outperformed the market in the last 3 month and 2 week periods, returning +4.9% and +9.5%, while SPY returned +4.4% and -0.3%, respectively. This indicates ATRA has been having a stronger performance recently.
ATRA support price is $8.27 and resistance is $9.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ATRA shares will trade within this expected range on the day.
